Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases

International Journal of Colorectal Disease

Volumn 25, Issue 10, 2010, Pages 1243-1249

  Liu, Jin Hwang ^a   Hsieh, Yao Yu ^a   Chen, Wei Shone ^a   Hsu, Yen Ning ^a   Chau, Gar Yang ^a   Teng, Hao Wei ^a   King, Kuang Liang ^a   Lin, Tzu Chen ^a   Tzeng, Chen Hwai ^a   Lin, Jen Kou ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Adjuvant chemotherapy; Colorectal liver metastasis; Irinotecan; Metachronous; Oxaliplatin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77956181586     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-0996-4     Document Type: Article

References (27)

1. R Stangl A Altendorf-Hofmann RM Charnley, et al. 1994 Factors influencing the natural history of colorectal liver metastases Lancet 343 1405 1410 10.1016/S0140-6736(94)92529-1 1:STN:280:DyaK2c3lsVGhug%3D%3D 7515134
2. J Scheele R Stangl A Altendorf-Hofmann, et al. 1995 Resection of colorectal liver metastases World J Surg 19 59 71 10.1007/BF00316981 1:STN:280:DyaK2M3lvFeltw%3D%3D 7740812
3. Y Fong J Fortner RL Sun, et al. 1999 Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 309 318 10.1097/00000658-199909000-00004 1:STN:280:DyaK1MvitFahsw%3D%3D 10493478
4. Y Sugawara J Yamamoto S Yamasaki, et al. 2001 Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy Surgery 129 408 413 1:STN:280:DC%2BD3M3js12jsg%3D%3D 11283530
5. MA Choti JV Sitzmann MF Tiburi, et al. 2002 Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 759 766 10.1097/00000658-200206000-00002 12035031
6. R Adam G Pascal D Azoulay, et al. 2003 Liver resection for colorectal metastases: the third hepatectomy Ann Surg 238 871 883 10.1097/01.sla. 0000098112.04758.4e 14631224
7. M Hebbar FR Pruvot O Romano, et al. 2009 Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer Cancer Treat Rev 35 668 675 10.1016/j.ctrv.2009.08.005 1:CAS:528:DC%2BD1MXhsVGlsb3K 19733977
8. MM Kemeny S Adak B Gray, et al. 2002 Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study J Clin Oncol 20 1499 1505 10.1200/JCO.20.6.1499 11896097
9. G Portier D Elias O Bouche, et al. 2006 Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial J Clin Oncol 24 4976 4982 10.1200/JCO.2006.06.8353 1:CAS:528:DC%2BD28Xht1GnurzP 17075115
10. B Nordlinger H Sorbye B Glimelius, et al. 2008 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial Lancet 371 1007 1016 10.1016/S0140-6736(08)60455-9 1:CAS:528: DC%2BD1cXjs1Sltbg%3D 18358928
11. E Mitry ALA Fields H Bleiberg, et al. 2008 Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials J Clin Oncol 26 4906 4911 10.1200/JCO.2008.17. 3781 1:CAS:528:DC%2BD1cXhtlGitrzJ 18794541
12. T André C Boni M Navarro, et al. 2009 Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 3109 3116 10.1200/JCO.2008.20.6771 19451431
13. C Tournigand T André E Achille, et al. 2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 229 237 10.1200/JCO.2004.05.113 1:CAS:528:DC%2BD2cXpsVKit7w%3D 14657227
14. SY Kim HJ Kim YS Hong, et al. 2009 Resected colorectal liver metastases: does the survival differ according to postoperative chemotherapy regimen? J Surg Oncol 100 713 718 10.1002/jso.21403 1:CAS:528:DC%2BC3cXht1agsrw%3D 19771561
15. X Wang DL Hershman JA Abrams, et al. 2007 Predictors of survival after hepatic resection among patients with colorectal liver metastasis Br J Cancer 97 1606 1612 10.1038/sj.bjc.6604093 1:STN:280:DC%2BD2sjjsVKhtA%3D%3D 18071347
16. A de Gramont A Figer M Seymour, et al. 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947 10944126
17. H Kelly RM Goldberg 2005 Systemic therapy for metastatic colorectal cancer: current options, current evidence J Clin Oncol 23 4553 4560 10.1200/JCO.2005.17.749 1:CAS:528:DC%2BD2MXnsl2ksLs%3D 16002847
18. A de Gramont JF Bosset C Milan, et al. 1997 Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study J Clin Oncol 15 808 815 9053508
19. R Goldberg DJ Sargent RF Morton, et al. 2004 A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 23 30 10.1200/JCO.2004.09.046 1:CAS:528:DC%2BD2cXpsVKitbY%3D 14665611
20. S Cheeseman S Joel J Chester, et al. 2002 A "modified de Gramont" regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer Br J Cancer 87 393 399 10.1038/sj.bjc.6600467 1:CAS:528:DC%2BD38XmtVOntbY%3D 12177775
21. T Andre C Louvet 1999 Maindrault-Goebel F et al CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer Eur J Cancer 35 1343 1347 10.1016/S0959-8049(99)00150-1 1:CAS:528:DyaK1MXls1Wjsbs%3D 10658525
22. S Merkel D Bialecki T Meyer, et al. 2009 Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases J Surg Oncol 100 349 357 10.1002/jso.21346 19572329
23. M Bockhorn GC Sotiropoulos G Sgourakis, et al. 2009 Major liver resections in the elderly-is an aggressive approach justified? Int J Colorectal Dis 24 83 86 10.1007/s00384-008-0571-4 18766356
24. J Xu Y Wei Y Zhong, et al. 2009 Hepatectomy for liver metastasis of colorectal cancer Int J Colorectal Dis 24 419 425 10.1007/s00384-008-0619-5 19096855
25. S Gill CL Loprinzi DJ Sargent, et al. 2004 Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22 1797 1806 10.1200/JCO.2004.09.059 1:CAS:528:DC%2BD2cXptlClu7Y%3D 15067028
26. N Kemeny Y Huang AM Cohen, et al. 1999 Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer N Engl J Med 341 2039 2048 10.1056/NEJM199912303412702 1:STN:280: DC%2BD3c%2FmtF2qtA%3D%3D 10615075
27. SR Alberts MS Roh MR Mahoney, et al. 2010 Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66 J Clin Oncol 28 853 858 10.1200/JCO.2009.24.6728 20048179